Pink Sheet is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183
Printed By
TAP's Prevacid: AWP of Takeda-Abbott's proton pump inhibitor lansoprazole is $97.51 for 30 15 mg delayed-release capsules and $325 for 100 30 mg caps, Medi-Span reports. Per-month cost is lower than that for Astra Merck's Prilosec (omeprazole), which lists an AWP of $108.90 for 30 20 mg controlled-release caps. Prevacid was approved May 10 ("The Pink Sheet" May 15, p. 3)...
| Table |
|---|
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.
